Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

Hamilton Health Sciences Corporation · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
hccradiation
hepatocellular carcinoma (hcc), durvalumab/tremelimumab, sbrt, radiation, hcc, woo, window of opportunity, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 967377
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.